コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tion (determined by immunohistochemistry for proliferating cell nuclear antigen).
2 E), tartrate-resistant acid phosphatase, and proliferating cell nuclear antigen.
3 replication and requires an interaction with proliferating cell nuclear antigen.
4 h cyclin-dependent kinase 2 (CDK2), CDK4 and proliferating cell nuclear antigen.
5 polymerase-alpha and the replication clamp, proliferating cell nuclear antigen.
8 nuclear staining, and AAF co-localized with proliferating cell nuclear antigen, a marker for replica
9 The degradation of Gcn5 is not dependent on proliferating cell nuclear antigen, an important player
12 ion protein A, replication factor C-Delta1N, proliferating cell nuclear antigen and DNA polymerase de
13 pproximately 10-fold in the presence of both proliferating cell nuclear antigen and DNA, but the acti
15 by several variables (BrdUrd incorporation, proliferating cell nuclear antigen and mitotic indices,
16 A replication initiation and associated with proliferating cell nuclear antigen and other components
18 proliferating cells with antibodies against proliferating cell nuclear antigen and phosphorylated hi
19 pletes excision repair via interactions with proliferating cell nuclear antigen and replication facto
20 he hyperplasia was associated with increased proliferating cell nuclear antigen and tenascin-C expres
22 on and increased apoptosis, as determined by proliferating cell nuclear antigen and terminal deoxynuc
26 en, tumor vasculature, and the expression of proliferating cell nuclear antigen and the proangiogenic
28 (h) markers of cell proliferation (Ki-67 and proliferating cell nuclear antigen) and angiogenesis (in
29 on (ILK1, phosphorylated Akt, cyclin D1, and proliferating cell nuclear antigen) and angiogenesis (pl
30 selectively increased expression of IGF-II, proliferating cell nuclear antigen, and aspartyl-(aspara
32 ontaining a ubiquitylation-resistant form of proliferating cell nuclear antigen, and chromatin loadin
33 AT-5 were activated, and cell proliferation, proliferating cell nuclear antigen, and cyclin D1 expres
34 ation (cyclooxygenase-2, prostaglandin E(2), proliferating cell nuclear antigen, and cyclin D1) and p
37 In reconstituted human systems, MutSalpha, proliferating cell nuclear antigen, and replication fact
38 fects resulted in PASMC proliferation (Ki67, proliferating cell nuclear antigen, and WST1 assays) and
40 the first structural characterization of the proliferating-cell-nuclear-antigen-associated factor p15
41 n recognition complexes, GINS complexes, and proliferating cell nuclear antigen at sites of DNA repli
42 omatin immunoprecipitation assay showed that proliferating cell nuclear antigen, ATR, TopBP1, and Chk
44 tethers it to the leading strand, and PCNA (proliferating cell nuclear antigen) binds tightly to Pol
45 were determined by methyltetrazolium, Ki-67, proliferating cell nuclear antigen, bromodeoxyuridine, a
47 -cells, macrophages, mature dendritic cells, proliferating cell nuclear antigen+ cells, and monocyte
48 show that NEIL1 binarily interacts with the proliferating cell nuclear antigen clamp loader replicat
50 Examination of S phase markers, specifically proliferating cell nuclear antigen, cyclin A, and 5-brom
51 o examine the mRNA and protein expression of proliferating cell nuclear antigen, cyclin D1, E-cadheri
53 or how nucleosome binding protects Set8 from proliferating cell nuclear antigen-dependent degradation
54 ore processive than hPol delta in supporting proliferating cell nuclear antigen-dependent elongation
56 phosphorylated Neu, cyclin D1, cyclin E, and proliferating cell nuclear antigen expression are observ
58 ently, Tyr(317) phosphorylation of p52(Shc), proliferating cell nuclear antigen expression, and cell
59 neration, 5-bromodeoxyuridine incorporation, proliferating cell nuclear antigen expression, and histo
61 l neurogenesis, measured by doublecortin and proliferating cell nuclear antigen expression, was also
63 t-specific TCP (TEOSINTE BRANCHED1/CYCLOIDEA/PROLIFERATING CELL NUCLEAR ANTIGEN FACTOR) family of DNA
64 instability 1 are responsible for unloading proliferating cell nuclear antigen from newly synthesize
66 -Rev1-Pol32 complex, irrespective of whether proliferating cell nuclear antigen has been loaded onto
67 matin-modifying enzymes or proteins, such as proliferating cell nuclear antigen, heterochromatin prot
68 ts stem from differences in stabilization of proliferating cell nuclear antigen in an open conformati
69 eased the levels of cyclin D1, E, and A, and proliferating cell nuclear antigen in meningeal cells wh
70 tion is essential for mono-ubiquitination of proliferating-cell nuclear antigen in response to oxidat
71 templates relies on its recently identified proliferating cell nuclear antigen-interacting motif, wh
73 ferating cell nuclear antigen via a putative proliferating cell nuclear antigen-interacting protein b
74 included demonstration that p12 possesses a proliferating cell nuclear antigen-interacting protein-d
75 cluding the catalytic polymerase domain, the proliferating cell nuclear antigen-interacting region, t
76 eferences in distinct regions, including the proliferating-cell-nuclear-antigen-interacting protein m
77 ed degradation suggesting that the p21(Cip1)-proliferating cell nuclear antigen interaction is critic
79 zed perfectly with FANCD2 and partially with proliferating cell nuclear antigen irrespective of mitom
80 d DNA ligase I, which compete for binding to proliferating cell nuclear antigen, is critical to preve
81 cells, as assessed by phospho histone H3 and proliferating cell nuclear antigen labeling, were also i
82 resulted in increased nuclear cyclin D1 and proliferating cell nuclear antigen levels and decreased
83 NA helicase, PolB, replication factor C, and proliferating cell nuclear antigen, long leading strands
84 )O(2) treatments both induced Rad18-mediated proliferating cell nuclear antigen mono-ubiquitination d
85 om the ubiquitin moiety of monoubiquitinated proliferating cell nuclear antigen (monoUb-PCNA) by the
86 ither translesion DNA synthesis initiated by proliferating cell nuclear antigen monoubiquitination or
87 localizing to sites of DNA damage, inducing proliferating cell nuclear antigen monoubiquitination, a
89 al DNA replication factors such as Cdc45 and proliferating cell nuclear antigen onto chromatin is blo
90 The eukaryotic DNA polymerase sliding clamp, proliferating cell nuclear antigen or PCNA, is a ring-sh
91 1 with double-flap DNA substrates and either proliferating cell nuclear antigen or the checkpoint sli
93 expression of pRb was undetectable, whereas proliferating cell nuclear antigen, p107, cyclin E, cycl
96 wn as the PIP degron, which binds DNA-loaded proliferating cell nuclear antigen (PCNA(DNA)) and recru
97 NA damage-independent mono-ubiquitination of proliferating cell nuclear antigen (PCNA) (a known Rad18
102 ociated with decreased platinum drug-induced proliferating cell nuclear antigen (PCNA) and FANCD2 mon
103 nase inhibitor Xic1 associates with trimeric proliferating cell nuclear antigen (PCNA) and is recruit
105 th muscle mass, paired box protein 7 (Pax7), proliferating cell nuclear antigen (PCNA) and nicotinami
106 fespan of replication factories by retaining proliferating cell nuclear antigen (PCNA) and other repl
107 omethylates non-histone substrates including proliferating cell nuclear antigen (PCNA) and promotes c
108 through its interactions with two proteins, Proliferating Cell Nuclear Antigen (PCNA) and Replicatio
110 the essential replication accessory protein proliferating cell nuclear antigen (PCNA) and the scaffo
111 rofiling of the multi-ubiquitinated proteins proliferating cell nuclear antigen (PCNA) and tubulin al
112 e show that the ternary complexes containing proliferating cell nuclear antigen (PCNA) and two non-cl
115 shown previously that the sliding DNA clamp proliferating cell nuclear antigen (PCNA) associates wit
116 ts Rad6-Rad18-mediated monoubiquitination of proliferating cell nuclear antigen (PCNA) at its Lys-164
117 he Rad6-Rad18 mediated monoubiquitylation of proliferating cell nuclear antigen (PCNA) at lys 164 pla
118 tial for redirecting SUMO conjugation to the proliferating cell nuclear antigen (PCNA) at lysine 164,
120 inally truncated CAF-1 p150 was deficient in proliferating cell nuclear antigen (PCNA) binding, reinf
121 es efficient mono- and polyubiquitination of proliferating cell nuclear antigen (PCNA) by regulating
122 oreover, artificial tethering of Polkappa to proliferating cell nuclear antigen (PCNA) circumvents th
123 n multiple transient events in the reaction: proliferating cell nuclear antigen (PCNA) clamp binding/
124 pre-steady-state analysis of ATP hydrolysis, proliferating cell nuclear antigen (PCNA) clamp opening,
125 cation factor C (RFC) complex loads circular proliferating cell nuclear antigen (PCNA) clamps onto DN
126 C (RFC) is a five-subunit complex that loads proliferating cell nuclear antigen (PCNA) clamps onto pr
127 nd the homotrimeric Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) clamps using s
128 of alpha-smooth muscle actin (alpha-SMA) and proliferating cell nuclear antigen (PCNA) compared with
129 ional significance of the human MutSalpha(.) proliferating cell nuclear antigen (PCNA) complex in mis
131 inding protein 1 (Ebp1), a key in regulating proliferating cell nuclear antigen (PCNA) expression and
133 s a mismatch, MutSalpha/beta, and DNA-loaded proliferating cell nuclear antigen (PCNA) for activation
136 nery, we found that ATM co-precipitates with proliferating cell nuclear antigen (PCNA) from cellular
138 xyuridine (EdU) labeling as well as Ki67 and proliferating cell nuclear antigen (PCNA) immunofluoresc
139 e/lysine mutants of Saccharomyces cerevisiae proliferating cell nuclear antigen (PCNA) in replication
140 monoubiquitylates the sliding clamp protein proliferating cell nuclear antigen (PCNA) in response to
141 "PIP degron," which consists of a canonical proliferating cell nuclear antigen (PCNA) interaction mo
155 nditions of an alternating light/dark cycle, proliferating cell nuclear antigen (PCNA) levels in tumo
158 esion and a helix perturbation that supports proliferating cell nuclear antigen (PCNA) loading by rep
159 early and mid-S phase and during DNA repair, proliferating cell nuclear antigen (PCNA) loading onto D
161 provide a permissive condition for inducing proliferating cell nuclear antigen (PCNA) monoubiquitina
162 c expression of USP7 promoted the UV-induced proliferating cell nuclear antigen (PCNA) monoubiquitina
164 oaded onto DNA, the eukaryotic sliding clamp Proliferating Cell Nuclear Antigen (PCNA) must be splaye
165 s in ID complex activation by ubiquitylating proliferating cell nuclear antigen (PCNA) on Lys164, an
166 loading of cyclin-dependent kinase (CDK) and proliferating cell nuclear antigen (PCNA) onto chromatin
167 ys, mediated by the interaction of Cdt1 with proliferating cell nuclear antigen (PCNA) or with cyclin
170 nt studies have shown that monoubiquitinated proliferating cell nuclear antigen (PCNA) plays an impor
174 ns wherein the interaction between RECQ5 and proliferating cell nuclear antigen (PCNA) promotes RAD18
175 The DNA polymerase delta processivity factor Proliferating Cell Nuclear Antigen (PCNA) promotes the D
176 its binding of a PIP-box sequence peptide to proliferating cell nuclear antigen (PCNA) protein by com
177 eration, and apoptosis in liver sections and proliferating cell nuclear antigen (PCNA) protein expres
179 e lagging strand template and anchors to the proliferating cell nuclear antigen (PCNA) sliding clamp
180 merase delta (pol delta), functions with the proliferating cell nuclear antigen (PCNA) sliding clamp.
181 gh processivity in synthesizing DNA with the proliferating cell nuclear antigen (PCNA) sliding clamp;
182 ted, while raised levels of doublecortin and Proliferating Cell Nuclear Antigen (PCNA) suggested incr
183 alian genomes and the activation of NEIL1 by proliferating cell nuclear antigen (PCNA) suggested pref
184 in the recruitment of the DNA clamp protein proliferating cell nuclear antigen (PCNA) to DNA lesions
185 ication fork stalling and mono-ubiquitinates proliferating cell nuclear antigen (PCNA) to facilitate
186 nd Lannigan sheds light on the regulation of proliferating cell nuclear antigen (PCNA) turnover and h
188 etabolic activities, MutSbeta interacts with proliferating cell nuclear antigen (PCNA) via a conserve
189 show that Bub1 constitutively interacts with proliferating cell nuclear antigen (PCNA) via a highly c
190 cells divide in the brain mantle and express proliferating cell nuclear antigen (PCNA), a cell cyclin
191 at control cellular proliferation, including proliferating cell nuclear antigen (PCNA), a cofactor as
192 cation forks through an interaction with the proliferating cell nuclear antigen (PCNA), a DNA polymer
193 and excision repair via an interaction with proliferating cell nuclear antigen (PCNA), a DNA sliding
194 -shaped virus 2 (SIRV2) and the host-encoded proliferating cell nuclear antigen (PCNA), a key DNA rep
198 capsular bags to determine the expression of proliferating cell nuclear antigen (PCNA), alpha-smooth
199 escribe a novel interaction between Chk1 and proliferating cell nuclear antigen (PCNA), an essential
200 from Thermoplasma acidophilum interact with proliferating cell nuclear antigen (PCNA), an essential
201 es p21(WAF1), increases p21(WAF1) binding to proliferating cell nuclear antigen (PCNA), and decreases
203 proteins Msh3, Msh6, and Mlh1 interact with proliferating cell nuclear antigen (PCNA), and mutations
204 n of Kdm4d impairs the recruitment of Cdc45, proliferating cell nuclear antigen (PCNA), and polymeras
205 ion, as evidenced by stabilization of Mcl-1, proliferating cell nuclear antigen (PCNA), and pro-caspa
206 reaction requiring Msh2-Msh6 (or Msh2-Msh3), proliferating cell nuclear antigen (PCNA), and replicati
208 hen the Rad6/Rad18 complex monoubiquitinates proliferating cell nuclear antigen (PCNA), but the basis
209 Spd1 with the polymerase processivity factor proliferating cell nuclear antigen (PCNA), complexed ont
210 UV-induced DNA damage and monoubiquitinates proliferating cell nuclear antigen (PCNA), facilitating
211 st time, the ATP-binding capability of human proliferating cell nuclear antigen (PCNA), identified th
212 on of p-mTOR, VEGF, cleaved caspase 3 (CC3), proliferating cell nuclear antigen (PCNA), IGF1, IGF1R,
213 oleta precludes its ability to interact with proliferating cell nuclear antigen (PCNA), it enhances i
214 rogenitors by assaying for the expression of proliferating cell nuclear antigen (PCNA), N-cadherin an
215 ssive replication with the replication clamp proliferating cell nuclear antigen (PCNA), respectively.
216 alysis revealed markedly decreased levels of proliferating cell nuclear antigen (PCNA), Runt-related
219 A We show that Rad51 inhibits recruitment of proliferating cell nuclear antigen (PCNA), the platform
220 and chromatin assembly might be governed by proliferating cell nuclear antigen (PCNA), the processiv
222 ed in the lamin C terminus binds directly to proliferating cell nuclear antigen (PCNA), the processiv
223 ated forms of the replicative sliding clamp, proliferating cell nuclear antigen (PCNA), the UBZ domai
224 tes the DNA damage-induced ubiquitination of proliferating cell nuclear antigen (PCNA), which facilit
225 o that of the eukaryotic processivity factor proliferating cell nuclear antigen (PCNA), which interac
226 KC-beta1 and PKC-gamma were colocalized with proliferating cell nuclear antigen (PCNA)- and STAT3-pos
227 l31 and Pol32 subunits are also required for proliferating cell nuclear antigen (PCNA)-dependent TLS
229 ed approximately 50% (P < 0.001) decrease in proliferating cell nuclear antigen (PCNA)-positive cells
230 action between the Enok complex and the Elg1 proliferating cell nuclear antigen (PCNA)-unloader compl
255 be stimulated by processivity clamps such as proliferating cell nuclear antigen (PCNA); however, the
256 ient for loading the heterotrimeric PCNA123 [proliferating cell nuclear antigen (PCNA)] clamp onto DN
257 single-molecule experiments using the yeast proliferating cell nuclear antigen (PCNA, clamp) and rep
259 of infiltrating leukocytes, myeloperoxidase, proliferating cell-nuclear antigen (PCNA), COX-2, PGE2,
260 sion of stem cell markers (Pax6, Oct3/4, and proliferating cell nuclear antigen [PCNA]), neuronal mar
261 actor Pax6; POU transcription factor Oct3/4; proliferating cell nuclear antigen [PCNA]); of neuronal
262 s collected to determine cell proliferation (proliferating cell nuclear antigen; PCNA) or calcium cha
263 prototypical housekeeping gene encoding the proliferating cell nuclear antigen (Pfpcna) around an in
264 n, proliferative activity (analyses of Ki67, proliferating cell nuclear antigen, phosphorylated histo
265 is synthesis is dependent on the activity of proliferating cell nuclear antigen, Pol-delta, and Pol-e
266 This correlated with decreased staining of proliferating cell nuclear antigen-positive cells and in
267 ant acid-phosphatase-positive cells and more proliferating cell nuclear antigen-positive cells in all
268 ric and had an increased number of Ki67- and proliferating cell nuclear antigen-positive cells; incre
269 s evident in TG mice, with higher numbers of proliferating cell nuclear antigen-positive hepatocytes
270 and 28 days, coinciding with an increase in proliferating cell nuclear antigen-positive hepatocytes.
271 heterozygous fish also showed an increase in proliferating cell nuclear antigen-positive renal tubule
272 gnificantly reduced (P < 0.05) the number of proliferating cell nuclear antigen-positive tubular epit
273 ruption of the interaction between XEco2 and proliferating cell nuclear antigen prevents cohesion est
274 e pathway dependent on polyubiquitylation of proliferating cell nuclear antigen provides a backup mec
276 utS alpha, MutL alpha, replication factor C, proliferating cell nuclear antigen, replication protein
277 sion by the replicative DNA polymerase delta/proliferating cell nuclear antigen/replication factor C
279 esis phase of the cell cycle (e.g. P. patens proliferating cell nuclear antigen, ribonucleotide reduc
280 SCC and expression of proliferative markers (proliferating cell nuclear antigen, signal transducers a
281 -1-1 complex) is structurally similar to the proliferating cell nuclear antigen sliding clamp and has
282 resulted in accumulation of chromatin-bound proliferating cell nuclear antigen, slowed cell division
284 requires replication accessory factors like proliferating cell nuclear antigen to achieve rapid rate
285 in the presence of replication factor C and proliferating cell nuclear antigen to perform efficient
286 vitro of GHRH and its antagonist JMR-132 on proliferating cell nuclear antigen, tumor suppressor pro
287 gy with Cavalieri estimation; apoptosis with proliferating cell nuclear antigen, TUNEL, and caspase a
288 ts using serial sections and perform IHC for proliferating cell nuclear antigen, upstream binding fac
289 t impede replication by ubiquitinating PCNA (proliferating cell nuclear antigen) using the RAD6-RAD18
290 of histone H4 during S phase by tethering to proliferating cell nuclear antigen via a putative prolif
291 e upon chronic cholestasis, but unexpectedly proliferating cell nuclear antigen was down-regulated at
293 to promote senescence, whereas cyclin D1 and proliferating cell nuclear antigen were decreased to red
294 E), tartrate-resistant acid phosphatase, and proliferating cell nuclear antigen were evaluated by his
297 ed arteries as indicated by co-staining with proliferating cell nuclear antigen, whereas Notch3 was e
298 NICHROMOSOME MAINTENANCE 2-7 gene family and PROLIFERATING CELL NUCLEAR ANTIGEN, which encode essenti
299 ppaB, Tnfrsf1b, and the proliferation marker proliferating cell nuclear antigen while also displaying
300 we explore the interactions of S. cerevisiae Proliferating Cell Nuclear Antigen (yPCNA) with modified
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。